Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Fallopian Tube Neoplasms × atezolizumab × Clear all

Phase

Status

Completed 2 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 15 Melanoma 5 Triple Negative Breast Neoplasms 4 Small Cell Lung Carcinoma 4 Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma, Hepatocellular 4 Breast Neoplasms 4 Head and Neck Neoplasms 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Mesothelioma, Malignant 2 Gastrointestinal Neoplasms 2 Carcinoma, Merkel Cell 2 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Small Cell Lung Cancer Recurrent 1 Safety Issues 1 Recurrent Liver Cancer After Liver Transplantation 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms, Squamous Cell 1 Neoplasm Metastasis 1 Lymphoma 1 Lung Neoplasms 1 Liver Neoplasms 1 Kidney Neoplasms 1 Hodgkin Disease 1 Fallopian Tube Neoplasms 1 Esophageal Neoplasms 1

Interventions

Paclitaxel 16 Carboplatin 15 Bevacizumab 5 Taxes 3 Hyperthermic Intraperitoneal Chemotherapy 3 Gemcitabine 3 Cisplatin 3 Chemotherapy, Adjuvant 3 pembrolizumab 2 oregovomab 2 niraparib 2 fluzoparib 2 Topotecan 2 ST 1481 2 Neoadjuvant Therapy 2 Methods 2 Immunohistochemistry 2 Ifosfamide 2 Gene Expression Profiling 2 Filgrastim 2 Educational Status 2 Early Intervention, Educational 2 Cytoreduction Surgical Procedures 2 Amplified Fragment Length Polymorphism Analysis 2 rucaparib 1 paclitaxel poliglumex 1 olaparib 1 navicixizumab 1 mirvetuximab soravtansine 1 liposomal doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03363867 2023-08-07

BEACON

Peter MacCallum Cancer Centre, Australia

Phase 2 Unknown

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡